Similar articles for PMID: 30719642

Year	Number of Results
2006	1
2007	1
2008	1
2009	1
2010	1
2011	1
2012	3
2013	4
2014	5
2015	13
2016	18
2017	14
2018	20
2019	7
2020	2
2021	5
2022	1
2023	1
2024	0

1

Blood-Based Biomarkers in High Grade Gliomas: a Systematic Review.

Pierscianek D, Ahmadipour Y, Oppong MD, Rauschenbach L, Kebir S, Glas M, Sure U, Jabbarli R. Pierscianek D, et al. Mol Neurobiol. 2019 Sep;56(9):6071-6079. doi: 10.1007/s12035-019-1509-2. Epub 2019 Feb 4. Mol Neurobiol. 2019. PMID: 30719642

2

Sex-dependent association of preoperative hematologic markers with glioma grade and progression.

Xu W, Wang D, Zheng X, Ou Q, Huang L. Xu W, et al. J Neurooncol. 2018 Apr;137(2):279-287. doi: 10.1007/s11060-017-2714-3. Epub 2017 Dec 19. J Neurooncol. 2018. PMID: 29260361

3

A panel of four cytokines predicts the prognosis of patients with malignant gliomas.

Lin Y, Zhang G, Zhang J, Gao G, Li M, Chen Y, Wang J, Li G, Song SW, Qiu X, Wang Y, Jiang T. Lin Y, et al. J Neurooncol. 2013 Sep;114(2):199-208. doi: 10.1007/s11060-013-1171-x. Epub 2013 Jun 8. J Neurooncol. 2013. PMID: 23748572

4

Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.

Kiviniemi A, Gardberg M, Frantzén J, Parkkola R, Vuorinen V, Pesola M, Minn H. Kiviniemi A, et al. J Neurooncol. 2015 Sep;124(2):237-45. doi: 10.1007/s11060-015-1829-7. Epub 2015 Jun 2. J Neurooncol. 2015. PMID: 26033547

5

Antiangiogenic therapy for high-grade glioma.

Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N. Khasraw M, et al. Cochrane Database Syst Rev. 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. Cochrane Database Syst Rev. 2014. PMID: 25242542 Updated. Review.

6

Altered galectin-1 serum levels in patients diagnosed with high-grade glioma.

Verschuere T, Van Woensel M, Fieuws S, Lefranc F, Mathieu V, Kiss R, Van Gool SW, De Vleeschouwer S. Verschuere T, et al. J Neurooncol. 2013 Oct;115(1):9-17. doi: 10.1007/s11060-013-1201-8. Epub 2013 Jul 4. J Neurooncol. 2013. PMID: 23824536

7

Do Selected Blood Inflammatory Markers Combined with Radiological Features Predict Proliferation Index in Glioma Patients?

Weng Y, Zhang X, Han J, Ouyang L, Liang M, Shi Z, Liu A, Cai W. Weng Y, et al. World Neurosurg. 2018 Oct;118:e137-e146. doi: 10.1016/j.wneu.2018.06.142. Epub 2018 Jun 26. World Neurosurg. 2018. PMID: 29959082

8

Corpus callosum involvement and postoperative outcomes of patients with gliomas.

Chen KT, Wu TW, Chuang CC, Hsu YH, Hsu PW, Huang YC, Lin TK, Chang CN, Lee ST, Wu CT, Tseng CK, Wang CC, Pai PC, Wei KC, Chen PY. Chen KT, et al. J Neurooncol. 2015 Sep;124(2):207-14. doi: 10.1007/s11060-015-1823-0. Epub 2015 Jun 2. J Neurooncol. 2015. PMID: 26033546

9

The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.

Bashir A, Brennum J, Broholm H, Law I. Bashir A, et al. J Neurosurg. 2018 Apr 6;130(2):451-464. doi: 10.3171/2017.8.JNS171577. J Neurosurg. 2018. PMID: 29624154

10

Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma.

Shu C, Wang Q, Yan X, Wang J. Shu C, et al. J Mol Neurosci. 2018 Apr;64(4):491-500. doi: 10.1007/s12031-018-1049-7. Epub 2018 Mar 3. J Mol Neurosci. 2018. PMID: 29502292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year